These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 20557684)

  • 1. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal corticosteroids in the treatment of allergic rhinitis.
    Ratner PH; Stoloff S; Meltzer EO; Hadley JA
    Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciclesonide nasal spray: in allergic rhinitis.
    Dhillon S; Wagstaff AJ
    Drugs; 2008; 68(6):875-83. PubMed ID: 18416590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis.
    Ratner PH; Wingertzahn MA; van Bavel JH; Hampel F; Darken PF; Shah T
    J Allergy Clin Immunol; 2006 Nov; 118(5):1142-8. PubMed ID: 17088141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis.
    Chervinsky P; Kunjibettu S; Miller DL; Prenner BM; Raphael G; Hall N; Shah T
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):69-76. PubMed ID: 17650833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis.
    Ratner PH; Wingertzahn MA; van Bavel JH; Hampel F; Darken PF; Hellbardt S; Brookman S; Shah T
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):657-63. PubMed ID: 17165276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
    Kim K; Quesada J; Szmaydy-Rikken N; Darken P; Shah T
    J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of ciclesonide, 200 microg once daily, for the treatment of perennial allergic rhinitis.
    Meltzer EO; Kunjibettu S; Hall N; Wingertzahn MA; Murcia C; Berger W; LaForce C
    Ann Allergy Asthma Immunol; 2007 Feb; 98(2):175-81. PubMed ID: 17304887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
    Wingertzahn MA; Derebery MJ; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis.
    Ratner P; Darken P; Wingertzahn M; Shah T
    J Asthma; 2007 Oct; 44(8):629-33. PubMed ID: 17943573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
    Nave R; Herzog R; Laurent A; Wingertzahn MA
    Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis.
    LaForce C; van Bavel J; Meltzer EO; Wingertzahn MA
    Ann Allergy Asthma Immunol; 2009 Aug; 103(2):166-73. PubMed ID: 19739431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis.
    Couroux P; Kunjibettu S; Hall N; Wingertzahn MA
    Ann Allergy Asthma Immunol; 2009 Jan; 102(1):62-8. PubMed ID: 19205288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis.
    Patel P; Patel D; Kunjibettu S; Hall N; Wingertzahn MA
    Ear Nose Throat J; 2008 Jun; 87(6):340-53. PubMed ID: 18561117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and physician perspectives on the attributes of nasal allergy medications.
    Naclerio RM; Hadley JA; Stoloff S; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S11-7. PubMed ID: 18307839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis.
    Nave R; Wingertzahn MA; Brookman S; Kaida S; Matsunaga T
    J Clin Pharmacol; 2006 Apr; 46(4):461-7. PubMed ID: 16554455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Blaiss MS
    Allergy Asthma Proc; 2007; 28(2):145-52. PubMed ID: 17479597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 μg once daily, for the treatment of seasonal allergic rhinitis.
    Ratner P; Jacobs R; Mohar D; Huang H; Desai SY; Hinkle J
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):471-9. PubMed ID: 21130386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclesonide for the treatment of seasonal allergic rhinitis.
    Jacobs RL
    Expert Rev Clin Immunol; 2011 Nov; 7(6):735-41. PubMed ID: 22014013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE; Meltzer EO
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.